What is Pharmacovigilance?
An apple a day keeps the doctor away. But nothing ever keeps a researcher away. A researcher’s job is
the backbone of medical sciences. Clinical research is, therefore, a driving factor for the healthy survival
of human beings.
It is common knowledge that any drug, prior to being introduced to the market, undergoes multiple
clinical trials. The pharmaceutical-market identifies the ‘product life cycle’ of a new drug in 3-stages:
1) R&D
2) Time taken to launch the drug in the market
3) Launch of the drug in the market
The R&D stage is especially done to avoid adverse reactions to the human anatomy based off of multiple
benchmarks. However, once the drug is introduced to the market, it is again possibly subject to reacting
differently to different medical-conditions. Pharmacovigilance is the procedure that deals with the
monitoring of these effects and also the positive-effects of the drug on the people. It is otherwise known
as ‘the drug safety’ process.
Pharmacovigilance identifies how a new drug after a certain routine-dose may react adversely or
favorably to the body. The process also factors in the discomfort or complaints that a patient reports to
the doctor in accordance with their health condition. Other aspects are the composition of the other
medicines that an individual may take, the comorbidities and so on. It is a meticulous and accuracy
driven-job.
In light of the COVID19 scenario, pharmacovigilance is of colossal importance. Different companies
across the globe are putting their best minds to conducting R&D and clinical trials on the new drugs that
are being introduced. Clinical research, in the times of a global-recession, is booming to its finest
pinnacles.
We at ACRI, with our team of experts, understand the job-market with the changing times and have the
best placement layout for our candidates.
Join us to reward your brilliance with the job of your dreams.
Contact us on:
Call: +91 97416 00499
Email: info@acriindia.com
